Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A squamous cell carcinoma that arises from the penis and is characterized by the presence of malignant spindle-shaped cells.
No clinical trials have been registered for sarcomatoid penile squamous cell carcinoma.
6 publications have been identified in PubMed for sarcomatoid penile squamous cell carcinoma. Research spans Case Report / Case Series (50%), Epidemiology / Natural History (33%), and Review / Meta-Analysis (17%).
Diniz-Filho JFS (2025). [PMID: 39926554](https://pubmed.ncbi.nlm.nih.gov/39926554/). *ACS omega*. [Epidemiology / Natural History]
Huang Q (2025). [PMID: 40226050](https://pubmed.ncbi.nlm.nih.gov/40226050/). *Translational andrology and urology*. [Case Report / Case Series]
Ishiyama Y (2025). [PMID: 41301078](https://pubmed.ncbi.nlm.nih.gov/41301078/). *Cancers*. [Epidemiology / Natural History]
Antonov P (2024). [PMID: 39258104](https://pubmed.ncbi.nlm.nih.gov/39258104/). *Cureus*. [Case Report / Case Series]
Neuville P (2024). [PMID: 39581662](https://pubmed.ncbi.nlm.nih.gov/39581662/). *The French journal of urology*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 9:31 PM UTC
McAlpine SG (2024). [PMID: 38842396](https://pubmed.ncbi.nlm.nih.gov/38842396/). *The American Journal of dermatopathology*. [Case Report / Case Series]
AI-curated news mentioning sarcomatoid penile squamous cell carcinoma
Updated Aug 27, 2026
Recent research on penile squamous cell carcinoma reveals candidate prognostic features through paired genomic profiling of primary tumors and lymph-node metastases. This study enhances understanding of the disease's genetic landscape, potentially guiding future therapeutic strategies.
A recent study identifies TP53/p53 status as a significant prognostic marker in penile squamous cell carcinoma. This research, which includes a cohort study and meta-analysis, enhances understanding of disease progression and potential treatment strategies.
Recent research identifies GPS1 exon 9 mutations as a rare genetic event in the pathogenesis of penile squamous cell carcinoma. This discovery could enhance understanding of the disease's molecular mechanisms.